Clinical trial

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal…

NCT00118729 · GlaxoSmithKline, Industry · Completed

Key facts

NCT number NCT00118729
Title Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action
Official title A Randomized, Double Blind, Placebo-Controlled, Single-Dose, Parallel-Group Study to Evaluate the Onset of Action of a Single Dose of Intranasal GW685698X Aqueous Nasal Spray 100mcg in Adolescent and Adult Subjects (12 Years of Age and Older) With Seasonal Allergic Rhinitis Exposed to Ragweed Pollen…
Lead sponsor GlaxoSmithKline, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Rhinitis, Allergic, Seasonal
Intervention type Drug
Interventions GW685698X Aqueous Nasal Spray
Enrollment 380
Start date Apr 1, 2005
Primary completion Aug 1, 2005
Completion Aug 1, 2005
First posted Jul 12, 2005
Last update posted Sep 15, 2016
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies